Total Payments
$5,682
2024 Payments
$777.77
Companies
32
Transactions
282
Medicare Patients
8,132
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$5,647 (99.4%)
Education$34.27 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,647 | 280 | 99.4% |
| Education | $34.27 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,289 | 58 | $0 (2024) |
| GENZYME CORPORATION | $929.21 | 41 | $0 (2023) |
| GlaxoSmithKline, LLC. | $577.02 | 34 | $0 (2024) |
| ABBVIE INC. | $366.78 | 20 | $0 (2023) |
| PFIZER INC. | $309.66 | 20 | $0 (2024) |
| Pharming Healthcare, Inc. | $264.06 | 12 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $211.66 | 8 | $0 (2021) |
| Genentech USA, Inc. | $206.20 | 13 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $149.51 | 7 | $0 (2023) |
| Shire North American Group Inc | $135.18 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $777.77 | 37 | AstraZeneca Pharmaceuticals LP ($273.77) |
| 2023 | $816.06 | 33 | AstraZeneca Pharmaceuticals LP ($416.08) |
| 2022 | $597.29 | 31 | ABBVIE INC. ($217.41) |
| 2021 | $630.09 | 28 | Biohaven Pharmaceuticals, Inc. ($186.67) |
| 2020 | $421.87 | 23 | GENZYME CORPORATION ($158.27) |
| 2019 | $952.76 | 49 | GENZYME CORPORATION ($259.00) |
| 2018 | $739.32 | 42 | GlaxoSmithKline, LLC. ($177.35) |
| 2017 | $746.47 | 39 | GENZYME CORPORATION ($91.87) |
All Payment Transactions
282 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $3.18 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/07/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: BIOLOGIC | ||||||
| 10/31/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: Immunology | ||||||
| 10/22/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 10/08/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: Neuroscience | ||||||
| 10/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | Cycle Pharmaceuticals Inc | Sajazir (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: Immunology | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 09/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Respiratory | ||||||
| 08/26/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: Immunology | ||||||
| 08/22/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: BIOLOGIC | ||||||
| 07/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Respiratory | ||||||
| 07/15/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 06/05/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 06/03/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: BIOLOGIC | ||||||
| 05/05/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 04/26/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Respiratory | ||||||
| 04/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: RESPIRATORY | ||||||
| 04/15/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,898 | 30,004 | $1.3M | $336,585 |
| 2022 | 26 | 1,933 | 35,365 | $1.5M | $402,604 |
| 2021 | 29 | 2,069 | 34,398 | $1.5M | $409,435 |
| 2020 | 28 | 2,232 | 35,564 | $1.5M | $387,918 |
Total Patients
8,132
Total Services
135,331
Medicare Billing
$1.5M
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 130 | 12,566 | $502,640 | $149,606 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 171 | 300 | $105,000 | $28,808 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 188 | 416 | $104,000 | $26,803 | 25.8% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 86 | 8,604 | $171,320 | $26,720 | 15.6% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 77 | 3,981 | $98,965 | $25,950 | 26.2% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 128 | 2,084 | $83,360 | $19,090 | 22.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 95 | 108 | $49,440 | $15,470 | 31.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 73 | 73 | $23,290 | $9,625 | 41.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 47 | 47 | $26,720 | $7,902 | 29.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 101 | 235 | $35,250 | $7,216 | 20.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 148 | 580 | $34,540 | $6,168 | 17.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 81 | 105 | $18,900 | $4,169 | 22.1% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 85 | 185 | $13,875 | $2,830 | 20.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 93 | 104 | $10,400 | $1,790 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $5,850 | $1,756 | 30.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 77 | 83 | $5,478 | $803.27 | 14.7% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 68 | 92 | $9,060 | $671.95 | 7.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 14 | 15 | $3,960 | $596.25 | 15.1% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 13 | 34 | $1,224 | $268.31 | 21.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 26 | 36 | $1,434 | $181.25 | 12.6% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 67 | 89 | $965.00 | $87.05 | 9.0% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 14 | 17 | $255.00 | $70.96 | 27.8% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 103 | 237 | $2,370 | $5.60 | 0.2% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 146 | 15,489 | $619,560 | $193,344 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 258 | 687 | $171,800 | $47,275 | 27.5% |
About Dr. Thomas Johnson, MD
Dr. Thomas Johnson, MD is a Specialist healthcare provider based in North Andover, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922090430.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Johnson, MD has received a total of $5,682 in payments from pharmaceutical and medical device companies, with $777.77 received in 2024. These payments were reported across 282 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,647).
As a Medicare-enrolled provider, Johnson has provided services to 8,132 Medicare beneficiaries, totaling 135,331 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location North Andover, MA
- Active Since 08/19/2005
- Last Updated 05/08/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922090430
Products in Payments
- FASENRA (Biological) $610.06
- DUPIXENT (Biological) $561.38
- DUPIXENT (Drug) $488.85
- FASENRA (Drug) $410.37
- RUCONEST (Biological) $264.06
- TRELEGY ELLIPTA (Drug) $237.84
- NUCALA (Biological) $236.43
- NURTEC ODT (Drug) $233.87
- PANZYGA (Biological) $222.37
- VRAYLAR (Drug) $121.32
- Xolair (Biological) $119.17
- RINVOQ (Biological) $116.59
- ORLADEYO (Drug) $115.35
- TEZSPIRE (Biological) $101.08
- Xofluza (Drug) $87.03
- BREZTRI (Drug) $85.00
- UBRELVY (Drug) $79.68
- CUTAQUIG (Biological) $74.37
- NIOX VERO DEVICE (Device) $74.01
- SPIRIVA RESPIMAT (Drug) $70.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.